Research
Mixed
The prevalence of sleep problems is highest among COVID-19 patients (57%), followed by healthcare professionals (31%), and the general population (18%).
Target sleep interventions should prioritize COVID-19 patients and healthcare workers, as they face the highest risk of sleep disruption. For the general public, sleep issues are less prevalent but still significant (1 in 5 people).
GoodSupportsHIGH confidence
The corrected pooled estimated prevalence of sleep problems were 31% among healthcare professionals, 18% among the general population, and 57% among COVID-19 patients (all p-values < 0.05).
Why this rating
Meta-analysis of large sample sizes across 39 countries.
Source
Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis
Zainab Alimoradi et al. · EClinicalMedicine · 2021
DOI 10.1016/j.eclinm.2021.100916
Meta-analysis · 177 studiesCited 387×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →